![]() |
市場調查報告書
商品編碼
1750568
凍乾設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Lyophilization Equipment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024年,全球凍乾設備市場價值為70億美元,預計到2034年將以8.8%的複合年成長率成長,達到161億美元,這主要得益於癌症、糖尿病和心血管疾病等慢性疾病的日益流行。隨著包括生物製劑、疫苗和其他敏感藥物在內的長期治療需求的成長,對冷凍乾燥設備的需求也隨之成長。
冷凍乾燥是製藥和生物製藥行業必不可少的工藝,因為它有助於保持敏感治療藥物(包括疫苗、生物製劑和注射劑)的功效、穩定性和保存期限。冷凍乾燥過程透過冷凍乾燥去除水分,確保這些產品即使在嚴苛的儲存條件下也能長時間保持完整性。對於需要長期或持續治療的慢性疾病,例如癌症、糖尿病和心血管疾病,冷凍乾燥過程尤其重要。隨著這些疾病在全球的盛行率持續上升,預計對冷凍乾燥產品的需求將大幅增加。對這些持久、無水分治療藥物的需求直接影響冷凍乾燥設備市場的成長。隨著製藥和生物製藥公司不斷開發需要專門儲存解決方案的新型療法,對冷凍乾燥製程的依賴也將日益成長。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 70億美元 |
預測值 | 161億美元 |
複合年成長率 | 8.8% |
2024年,設備細分市場產值達到37億美元,這得益於市場對自動化、高通量、節能型冷凍乾燥設備(例如旋轉式凍乾機和托盤式冷凍乾燥機)日益成長的需求。這些設備尤其適用於大規模生產熱敏性產品,包括生物製劑和疫苗。此外,冷凍乾燥技術的不斷進步,例如即時監控能力以及對溫度和真空度等關鍵參數控制的改進,正在提升這些設備的效率,使其對製藥和生物製藥行業更具吸引力。
桌上型冷凍乾燥設備市場在2024年佔據46.3%的市場佔有率,預計到2034年將達到75億美元。桌上型設備因其緊湊的設計、具成本效益以及包括精確真空和溫度控制在內的先進功能,在實驗室、藥物開發和學術研究機構等小規模生產環境中備受青睞。這些特性使桌上型冷凍乾燥設備成為實驗研究和早期製劑開發的理想選擇。
受美國癌症發生率上升的推動,預計2034年,美國冷凍乾燥設備市場規模將達到47億美元。隨著癌症治療技術的不斷發展,許多製藥和生物技術公司正在投資開發穩定、先進的療法,例如疫苗和注射。凍乾技術支持這些腫瘤治療藥物的大規模生產,進一步推動市場擴張。
全球冷凍乾燥設備市場的主要參與者包括阿自倍爾 (Azbil)、GEA Group Aktiengesellschaft、MechaTech Systems、Millrock Technology 和 WL Gore & Associates 等公司。這些公司專注於創新,並不斷擴展產品線,以鞏固其市場地位。例如,Labconco 和 ZIRBUS technology 等公司強調節能且方便用戶使用的解決方案,而 Optima 和 Cuddon 等公司則正在探索整合先進的監控系統和自動化技術,以提高設備性能和可靠性。
The Global Lyophilization Equipment Market was valued at USD 7 billion in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 16.1 billion by 2034, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As the demand for long-term treatments, including biologics, vaccines, and other sensitive pharmaceuticals, rises, the need for lyophilization equipment grows.
Lyophilization is an essential process in the pharmaceutical and biopharmaceutical industries, as it helps preserve the efficacy, stability, and shelf life of sensitive therapeutics, including vaccines, biologics, and injectables. By removing moisture through freeze-drying, lyophilization ensures that these products maintain their integrity over extended periods, even under challenging storage conditions. This process is especially vital for chronic conditions that require long-term or ongoing treatment, such as cancer, diabetes, and cardiovascular diseases. As the global prevalence of these conditions continues to rise, the need for lyophilized products is expected to increase significantly. The demand for these long-lasting, moisture-free therapeutics has a direct impact on the growth of the lyophilization equipment market. As pharmaceutical and biopharmaceutical companies continue to develop new treatments that require specialized storage solutions, the reliance on lyophilization processes will grow.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $7 Billion |
Forecast Value | $16.1 Billion |
CAGR | 8.8% |
The devices segment generated USD 3.7 billion in 2024, driven by the increasing demand for automated, high-throughput, and energy-efficient freeze-drying equipment, such as rotary freeze dryers and tray-style dryers. These devices are especially useful in large-scale production of heat-sensitive products, including biologics and vaccines. Furthermore, continuous advancements in lyophilization technologies, such as real-time monitoring capabilities and improved control over critical parameters like temperature and vacuum, are enhancing the efficiency of these devices, making them more attractive to the pharmaceutical and biopharmaceutical sectors.
The bench-top lyophilization equipment segment held a 46.3% share in 2024 and is set to reach USD 7.5 billion by 2034. Bench-top units are favored in small-scale production settings, such as laboratories, pharmaceutical development, and academic research institutions, due to their compact design, cost-effectiveness, and advanced features, including precise vacuum and temperature control. These qualities make bench-top lyophilization equipment ideal for experimental studies and early-stage formulation development.
United States Lyophilization Equipment Market is expected to reach USD 4.7 billion by 2034, driven by the rising prevalence of cancer in the country. As cancer treatment continues to evolve, many pharmaceutical and biotechnology companies are investing in the development of stable, advanced therapies like vaccines and injectables. Lyophilization technology supports the large-scale production of these oncology treatments, further fueling market expansion.
Key players in the Global Lyophilization Equipment Market include companies such as Azbil, GEA Group Aktiengesellschaft, MechaTech Systems, Millrock Technology, and W. L. Gore & Associates. These companies are focusing on innovation and expanding their product offerings to strengthen their position in the market. For instance, firms like Labconco and ZIRBUS technology are emphasizing energy-efficient and user-friendly solutions, while companies such as Optima and Cuddon are exploring the integration of advanced monitoring systems and automation to improve device performance and reliability.